Literature DB >> 210595

Glucagonoma syndrome in a 19-year-old woman.

M C Riddle, T A Golper, W S Fletcher, J W Ensinck, P H Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210595      PMCID: PMC1238245     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  26 in total

1.  Some aspects of silver impregnation of the islets of Langerhans in the rat.

Authors:  C HELLERSTROEM; B HELLMAN
Journal:  Acta Endocrinol (Copenh)       Date:  1960-12

2.  A silver nitrate stain for alpha-2 cells in human pancreatic islets.

Authors:  L Grimelius
Journal:  Acta Soc Med Ups       Date:  1968

3.  Glucagonoma as part of the polyglandular adenoma syndrome.

Authors:  R J Croughs; H A Hulsmans; D E Israël; W H Hackeng; W Schopman
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

4.  Secretion by glucagonomas of a possible glucagon precursor.

Authors:  G C Weir; E S Horton; T T Aoki; D Slovik; J Jaspan; A H Rubenstein
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

Review 5.  Control of pancreatic IRG secretion in vivo.

Authors:  J E Gerich
Journal:  Metabolism       Date:  1976-11       Impact factor: 8.694

6.  Intraislet negative insulin-glucagon feedback.

Authors:  E Samols; J Harrison
Journal:  Metabolism       Date:  1976-11       Impact factor: 8.694

7.  Gut hormones and the alpha cell.

Authors:  S R Bloom; J Iversen
Journal:  Metabolism       Date:  1976-11       Impact factor: 8.694

8.  Evanescent effects of hypo- and hyperglucagonemia on blood glucose homeostasis.

Authors:  R Sherwin; J Wahren; P Felig
Journal:  Metabolism       Date:  1976-11       Impact factor: 8.694

9.  An islet cell carcinoma containing glucagon and insulin. Chronic glucagon excess and glucose homeostasis.

Authors:  G Boden; O E Owen; I Rezvani; B I Elfenbein; K E Quickel
Journal:  Diabetes       Date:  1977-02       Impact factor: 9.461

10.  Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".

Authors:  L Recant; P V Perrino; S J Bhathena; D N Danforth; R L Lavine
Journal:  Diabetologia       Date:  1976-08       Impact factor: 10.122

View more
  4 in total

1.  Inhibition of glucagon secretion by diphenylhydantoin in a patient with glucagonoma.

Authors:  T Machina; R Marcus; S R Levin
Journal:  West J Med       Date:  1980-04

Review 2.  Pancreatic glucagonoma with and without syndrome. Immunocytochemical study of 5 tumour cases and review of the literature.

Authors:  E Ruttman; G Klöppel; G Bommer; M Kiehn; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

3.  Glucagonoma and its angiographic diagnosis.

Authors:  A S Wawrukiewicz; J Rösch; F S Keller; D A Lieberman
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740

4.  Cystic glucagonoma: A rare variant of an uncommon neuroendocrine pancreas tumor.

Authors:  K Brown; T Kristopaitis; S Yong; G Chejfec; J Pickleman
Journal:  J Gastrointest Surg       Date:  1998 Nov-Dec       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.